ADAR1 Partners, LP
- SEC CIK
- 0001758866
In the past year, 1 open-market sale filing worth $95.7M and no purchases.
Current role at each company
- KROS Keros Therapeutics, Inc.10% Owneras of Oct 15, 2025
- PVLA Palvella Therapeutics, Inc.10% Owneras of Aug 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $95.7M
- 1 filing
- Net
- −$95.7M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists ADAR1 Partners, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KROS Keros Therapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 (view filing)9:57 PM ET | Apr 9 | 2 days | ADAR1 Partners, LP and 3 others10% Owner | PPurchase | +934.3K | $10.13 | +$9.46M | +27.0%4.39M after | 5 lots |
| Oct 15, 2025 (view filing)1:24 PM ET | Oct 15 | Same day | ADAR1 Partners, LP and 3 others10% Owner | SSale | −5.39M | $17.75 | −$95.7M | −100.0%0 after | 3 lots |
PVLA Palvella Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 (view filing)6:48 PM ET | Aug 9-12 | 3 days | ADAR1 Partners, LP and 1 other10% Owner | PPurchase | +6.00K | $15.39 | +$92.3K | +66.2%15.1K after | 3 lots |